It's not like there is any competition for that spot. All the other prophylactic drugs are now generic, and the triptans are split among a generic and half-a-dozen roughly equivalent branded drugs, some of which are also now nearing the end of their patent life and so are no longer detailed much.
Market Data 
Markets 
AI
